2023 US and Western Europe Cataract Pharmaceuticals Market Report, May, 2023

The “2023 US and Western Europe Cataract Pharmaceuticals Market Report” offers an in-depth examination of the current cataract pharmaceuticals market in the United States and Western Europe and forecasts market performance over the next five years. The report analyzes the current market and forecasts units, average sales price, and revenue through 2028 by product category. It analyzes products currently on the market and examines the development pipeline, discusses the popularity of intracameral injections and fixed combination eye drops, and analyzes the roles of brand name medications, generics, and compounded formulations.

This comprehensive report covers the United States and Western European markets and provides:

• Information on cataract incidence and cataract surgeries.
• Current estimates and five-year forecasts for cataract surgery volumes in the United States and Western Europe.
• Discussion of phakic and refractive lens exchange procedures.
• Forecasts for sales of antibiotics used in association with cataract surgery.
• Forecasts for sales of mydriatics and cycloplegics used in cataract surgery.
• Forecasts for sales of anti-inflammatory drugs and painkillers used in association with cataract surgery.
• Profile of cataract and cataract/refractive surgeons in the United States and Western Europe
• Information on corporate surgery providers.
• Discussion of current reimbursement levels.
• Descriptions of new products in development.

2 licensing types are available for this report:

• The price of the single-user license is $5,350.
• The price of the enterprise license is $8,025 (includes supplemental Excel file with all the tables and figures in the report, and report summary slides).

Both licenses include an electronic PDF. Printed copies may be purchased for an additional $250.

SINGLE USER LICENSE

• The Single User License allows for the use of a report by a single user within one corporate location.
• The report paper copy may not be reproduced (additional paper copies available for purchase).
• Report PDF copy can not be copied (if purchased) and must remain on one computer (not a company server).
• Only a single copy of the publication may be printed for internal use.
• Users may include information in the report in presentations and internal reports by providing full copyright credit to Market Scope.
• Users may not share the report (or any information contained therein) with any other person or persons outside the corporate location for which the report is purchased.

ENTERPRISE LICENSE

• The Enterprise License allows for the use of a report by unlimited users within the purchasing organization.
• Purchasing organization shall have the right to share the report with third parties. (investors, consultants, etc.) from time to time under the global license agreement, provided that such third parties have a confidentiality agreement with the purchasing organization and agree to be bound by the terms of the global license agreement.
• Employees of the purchasing organization can include information given in the report in presentations and internal reports by providing full copyright credit to Market Scope.
• Purchase price includes a printable PDF file of the report (purchasing organization may print multiple copies for use within the organization).
• Purchase price includes a supplemental Excel file containing all the tables and figures included in the purchased report.

Pay by credit card or by invoice.